Work

Outcomes of patients with mayo stage IIIb systemic AL amyloidosis treated with daratumumab-based frontline therapy

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-5740

Authors: Simon Zhen, Divaya Bhutani, Mathew Maurer, Karan Wats, Yevgeniy Brailovsky, Michael Hughes, Jai Radhakrishnan, Markus Mapara, Suzanne Lentzsch, Rajshekhar Chakraborty

Institutions: Columbia University Irving Medical Center, Columbia University, Herbert Irving Comprehensive Cancer Center

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417013025

Cites:

Cited by:

Related to: